Plant-based Complete Nutrition for Toddlers Trial Pouches to be widely available on
ElseNutrition.com e-store
VANCOUVER, BC, June 22, 2020 /CNW/ - ELSE NUTRITION HOLDINGS INC. (TSXV: BABY)(OTCQB: BABYF) (FSE: 0YL) ("Else" or the "Company"), is pleased to announce the U.S. launch of trial-sized pouches of Else Plant-based Complete Nutrition for Toddlers.
Following successful production, the trial samples of Else's proprietary product will now be widely available for order via the elsenutrition.com e-store.
"We are thrilled to hit this key milestone and to be sharing our product with the world. It is indeed a major inflection point as we continue down the path toward commercialization of our first product. We are excited to get the samples in the hands of eager parents looking for clean label, plant-based nutrition alternatives for their children," said Ms. Hamutal Yitzhak, CEO & Co-Founder.
Else Plant-Based Complete Nutrition for Toddlers trial pouches (1.27 oz) will be available at no charge, with customers covering only the shipping costs. The sampling campaign will be promoted via Else social media channels and will precede the launch of the full-size version of the product, which will be available for pre-orders on our e-store this July.
Samples can be ordered at: www.elsenutrition.com.
About Else Nutrition Holdings Inc.
Else Nutrition GH Ltd. is an Israel-based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the "2017 Best Health and Diet Solutions" award at the Global Food Innovation Summit in Milan. The holding company, Else Nutrition Holdings Inc, is a publicly-traded company, listed as TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets QB board under the trading symbol BABYF and on the Frankfurt Exchange under the symbol 0YL. Else's Executive and Advisory Board includes leaders hailing from Abbott Nutrition, Mead Johnson, Boston Children's Hospital, ESPGHAN (European Society for Pediatric Gastroenterology, Hepatology and Nutrition), University Hospital Brussels, Tel Aviv University's Sackler Faculty of Medicine, and Gastroenterology & Nutrition Institute of RAMBAM Medical Center, Plum Organics.
For more information, visit: elsenutrition.com or @elsenutrition on Facebook and Instagram.
TSX Venture Exchange
Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Caution Regarding Forward-Looking Statements
This press release contains statements that may constitute "forward-looking statements" within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as "will", "expect" or similar expressions. Forward-looking statements in this press release include statements with respect to the anticipated dates for filing the Company's financial disclosure documents. Such forward-looking statements reflect current estimates, beliefs and assumptions, which are based on management's perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Forward-looking statements made in this press release assume, among others, the expectation that listing on the FSE will create additional liquidity and attract additional investors in the European market. Actual results may differ from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements. Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management's expectations only as of the date of this press release. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
SOURCE Else Nutrition Holdings Inc.
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/June2020/22/c0408.html
Ms. Hamutal Yitzhak, CEO, Co-Founder & Director, ELSE Nutrition Holdings Inc., E: hamutaly@elsenutrition.com, P: +972(0)3-6445095; Mr. Sokhie Puar, Director of Else Nutrition, Email: sokhiep@elsenutrition.com, Telephone: 604-603-7787Copyright CNW Group 2020